Prism Medico & Pharmacy Ltd responded to BSE/MSEI query on significant recent price movement in its securities.
Company states all material disclosures under Regulation 30 of SEBI LODR have been made timely and accurately.
Management attributes price movement to speculative market conditions; confirms promoters and KMPs have not traded recently.